Home > Insider Trading > Filing (0001593968-17-000561)

Filing Details

Accession Number:: 0001593968-17-000561
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-04 11:11:54
Reporting Period:: 2017-03-31

Filing Date:: 2017-04-04
Accepted Time:: 2017-04-04 11:11:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1466026	Midland States Bancorp Inc.	MSBI	State Commercial Banks (6022)	371233196

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1526231	M John Schultz	1201 Network Centre Dr. Effingham IL 62401		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-04-03	1,000	$34.00	323,026	No	4	S	Direct
Common Stock	Disposition	2017-04-03	1,000	$34.01	87,903	No	4	S	Indirect	JNJ, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	JNJ, LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Share Equivalent	Acquisiton	2017-03-31	422	$34.39	422	$0.00
Common Stock	Common Share Equivalent	Acquisiton	2017-03-31	105	$34.39	105	$0.00
Common Stock	Common Share Equivalent	Acquisiton	2017-03-31	305	$34.39	305	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
52,791	No	4	A	Direct
52,896	No	4	A	Direct
53,201	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,750	Indirect	Spouse
Common Stock	42,554	Indirect	Agracel, Inc.

Footnotes

Includes holdings through a self-directed IRA or revocable grantor trust
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.0001 - $34.13 inclusive. The reporting person undertakes to provide to Midland States Bancorp, Inc., any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote 1 to this form.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose
Represents common share equivalents acquired by the reporting person under the Directors Deferred Compensation Plan (DDCP) of the Issuer with respect to directors fees deferred by the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Each common share equivalent is the economic equivalent of one share of common stock. Common share equivalents received for deferred director fees are fully vested on the transaction date listed above.
Common share equivalents become payable upon termination of service as a director except for any unvested portion of the Issuer matching contribution.
Represents common share equivalents acquired by the reporting person in the DDCP through the 25% Issuer matching contribution for the director fees paid to the reporting person during the quarter, based upon the closing price of the underlying shares on the last day of the quarter. Common share equivalents received for the Issuer matching contribution vest in four equal annual portions beginning on the first anniversary of the grant date, and unvested matching contributions are forfeited at the time service as a director terminates.
Represents common share equivalents acquired by the reporting person in the DDCP pursuant to the reinvestment of dividends received during the quarter on common share equivalents held in the DDCP by the reporting person at the time such dividend was paid on the underlying shares, based upon closing price of the underlying shares on the last day of the quarter. Common share equivalents received for dividend reinvestments are fully vested on the transaction date listed above and become payable upon termination of service as a director.